PH12014501760A1 - Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes - Google Patents

Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes

Info

Publication number
PH12014501760A1
PH12014501760A1 PH12014501760A PH12014501760A PH12014501760A1 PH 12014501760 A1 PH12014501760 A1 PH 12014501760A1 PH 12014501760 A PH12014501760 A PH 12014501760A PH 12014501760 A PH12014501760 A PH 12014501760A PH 12014501760 A1 PH12014501760 A1 PH 12014501760A1
Authority
PH
Philippines
Prior art keywords
undecanes
diaza
spiro
oxo
hydroxy
Prior art date
Application number
PH12014501760A
Other languages
English (en)
Other versions
PH12014501760B1 (en
Inventor
Schnaubelt Juergen
Tang Wenjun
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PH12014501760A1 publication Critical patent/PH12014501760A1/en
Publication of PH12014501760B1 publication Critical patent/PH12014501760B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH12014501760A 2012-02-09 2014-08-05 Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes PH12014501760B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12154688 2012-02-09
PCT/EP2013/052287 WO2013117568A1 (de) 2012-02-09 2013-02-06 Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Publications (2)

Publication Number Publication Date
PH12014501760A1 true PH12014501760A1 (en) 2014-11-10
PH12014501760B1 PH12014501760B1 (en) 2014-11-10

Family

ID=47678813

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501760A PH12014501760B1 (en) 2012-02-09 2014-08-05 Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes

Country Status (14)

Country Link
US (1) US8629146B2 (enExample)
EP (1) EP2812317B1 (enExample)
JP (1) JP6105631B2 (enExample)
KR (1) KR20140128318A (enExample)
CN (1) CN104080775A (enExample)
AU (1) AU2013218119A1 (enExample)
BR (1) BR112014019196A8 (enExample)
CA (1) CA2862520A1 (enExample)
CL (1) CL2014001823A1 (enExample)
EA (1) EA201400882A1 (enExample)
IL (1) IL233370A (enExample)
MX (1) MX2014009033A (enExample)
PH (1) PH12014501760B1 (enExample)
WO (1) WO2013117568A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
PL371188A1 (en) 2002-03-30 2005-06-13 Boehringer Ingelheim Pharma Gmbh & Co.Kg 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
KR20080077009A (ko) 2005-12-12 2008-08-20 베링거 인겔하임 인터내셔날 게엠베하 바이사이클릭 헤테로사이클, 당해 화합물을 함유하는 약제,이의 용도 및 이의 제조방법
EP2245026B1 (de) 2008-02-07 2012-08-01 Boehringer Ingelheim International GmbH Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
EP2289881A1 (de) 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
PE20141012A1 (es) 2011-02-01 2014-09-10 Boehringer Ingelheim Int Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion

Also Published As

Publication number Publication date
US20130211081A1 (en) 2013-08-15
BR112014019196A2 (enExample) 2017-06-20
CA2862520A1 (en) 2013-08-15
JP6105631B2 (ja) 2017-03-29
IL233370A0 (en) 2014-08-31
WO2013117568A1 (de) 2013-08-15
IL233370A (en) 2015-04-30
JP2015506966A (ja) 2015-03-05
KR20140128318A (ko) 2014-11-05
CL2014001823A1 (es) 2015-03-06
EP2812317A1 (de) 2014-12-17
MX2014009033A (es) 2014-10-17
US8629146B2 (en) 2014-01-14
CN104080775A (zh) 2014-10-01
PH12014501760B1 (en) 2014-11-10
EP2812317B1 (de) 2016-02-03
BR112014019196A8 (pt) 2017-07-11
AU2013218119A1 (en) 2014-07-17
EA201400882A1 (ru) 2015-01-30

Similar Documents

Publication Publication Date Title
PH12013500760B1 (en) Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
IN2015DN01061A (enExample)
TN2013000400A1 (en) Imidazopyridazines as akt kinase inhibitors
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
MX362689B (es) Procedimiento de preparacion de derivados de acido 3,5-bis(fluoroalquil)pirazol-4-carboxilico y 3,5-bis(fluoroalquil) pirazoles.
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
IN2014DN09053A (enExample)
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
GEP201706626B (en) Synthesis of (s)-nifuratel
NZ720106A (en) A process for the preparation of regadenoson
MX350430B (es) Proceso para preparar compuestos acido 4-amino-5-bifenil-4-il-2-hi droximetil-2-metil-pentanoico.
MX2012010317A (es) ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX361998B (es) Procedimiento de preparacion de derivados de acido 4-haloalquil-3-mercapto-2 sustituido-hidroxibenzoico.
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
MX343856B (es) Procedimiento para la preparación de derivados 1-h-pirrolidin-2,4-diona.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
PH12014501760A1 (en) Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes
IN2014DN07407A (enExample)
MX345822B (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
PH12015501840A1 (en) Production method of pyridazinone compounds
MX2013002395A (es) Procedimiento de preparacion de ditiin-tetracarboximidas.
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
IN2014CN02645A (enExample)